Filing Details

Accession Number:
0001415889-21-000237
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-06 18:02:41
Reporting Period:
2021-01-04
Accepted Time:
2021-01-06 18:02:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711968 Leonard Steven Chapman C/O Natera, Inc.
201 Industrial Rd Suite 410
San Carlos CA 94070
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-04 3,125 $0.00 38,722 No 4 M Direct
Common Stock Acquisiton 2021-01-04 335 $10.41 39,057 No 4 M Direct
Common Stock Acquisiton 2021-01-04 104 $10.73 39,161 No 4 M Direct
Common Stock Acquisiton 2021-01-04 153 $9.29 39,314 No 4 M Direct
Common Stock Acquisiton 2021-01-04 313 $13.01 39,627 No 4 M Direct
Common Stock Acquisiton 2021-01-04 1,875 $13.01 41,502 No 4 M Direct
Common Stock Acquisiton 2021-01-04 313 $20.27 41,815 No 4 M Direct
Common Stock Acquisiton 2021-01-04 239 $25.46 42,054 No 4 M Direct
Common Stock Disposition 2021-01-04 1,558 $99.49 40,496 No 4 S Direct
Common Stock Disposition 2021-01-04 3,332 $99.49 37,164 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-01-04 3,125 $0.00 3,125 $0.00
Common Stock Stock Option (right to buy) Disposition 2021-01-04 335 $0.00 335 $10.41
Common Stock Stock Option (right to buy) Disposition 2021-01-04 104 $0.00 104 $10.73
Common Stock Stock Option (right to buy) Disposition 2021-01-04 153 $0.00 153 $9.29
Common Stock Stock Option (right to buy) Disposition 2021-01-04 313 $0.00 313 $13.01
Common Stock Stock Option (right to buy) Disposition 2021-01-04 1,875 $0.00 1,875 $13.01
Common Stock Stock Option (right to buy) Disposition 2021-01-04 313 $0.00 313 $20.27
Common Stock Stock Option (right to buy) Disposition 2021-01-04 239 $0.00 239 $25.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 No 4 M Direct
10,837 2027-06-08 No 4 M Direct
5,105 2027-07-13 No 4 M Direct
48,687 2028-03-08 No 4 M Direct
53,854 2029-01-10 No 4 M Direct
79,375 2029-01-10 No 4 M Direct
60,104 2029-04-11 No 4 M Direct
42,031 2030-03-26 No 4 M Direct
Footnotes
  1. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting on January 2, 2020.
  2. Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  3. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1.
  4. The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
  5. The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
  6. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
  7. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
  8. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
  9. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
  10. This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of December 18, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.
  11. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
  12. The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares.